Skip to main content
CH

Checkpoint Therapeutics

Waltham, United States
Last funding
$12.0M
Post-IPO EquityJul 2024

Checkpoint Therapeutics is an immuno-oncology biopharmaceutical company specializing in cancer therapy development.

About Checkpoint Therapeutics

How much funding has Checkpoint Therapeutics raised?

Checkpoint Therapeutics has raised $12.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in July 2024.

Where is Checkpoint Therapeutics headquartered?

Checkpoint Therapeutics is headquartered in Waltham, United States.

What does Checkpoint Therapeutics do?

Checkpoint Therapeutics is an immuno-oncology biopharmaceutical company specializing in cancer therapy development.

What stage is Checkpoint Therapeutics at?

Checkpoint Therapeutics is at the Post-IPO Equity stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Checkpoint Therapeutics — Funding & Investors." VCBacked, July 2, 2024, https://www.vcbacked.co/company/checkpoint-therapeutics. Accessed November 15, 2026.
APA
VCBacked. (2024). Checkpoint Therapeutics — Funding & Investors. Retrieved November 15, 2026, from https://www.vcbacked.co/company/checkpoint-therapeutics
Wikipedia (cite web)
{{cite web |title=Checkpoint Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/checkpoint-therapeutics |website=VCBacked |access-date=November 15, 2026}}

Profile data sourced and verified per the VCbacked methodology · Last funding round dated

Work at Checkpoint Therapeutics? Request a listing update

Founder contacts
m***@checkpointtx.com
linkedin.com/in/●●●●●●
Emails, phones & LinkedIn · 41,000+ verified contacts
Get instant access →